Please login to order a test.
Clinical Utility Test List
|
Test Number |
Test Name |
|---|---|
|
Apolipoprotein A-1 |
|
|
Apolipoprotein Assessment |
|
|
Apolipoprotein B |
|
|
Lipid Cascade |
|
|
Lipid Panel |
|
|
Lipid Panel With LDL:HDL Ratio |
|
|
Lipid Panel With Non-HDL Cholesterol |
|
|
Lipid Panel With Total Cholesterol:HDL Ratio |
|
|
Lipoprotein (a) |
|
|
Low-density Lipoprotein Cholesterol (Direct) |
|
|
NMR LipoProfile® |
|
Test Number |
Test Name |
|---|---|
|
Inflammatory Markers |
|
|
C-Reactive Protein (CRP), High Sensitivity (Cardiac Risk Assessment) |
|
|
Fibrinogen Activity |
|
|
Fibrinogen Antigen |
|
|
Heart Disease and Stroke Risk Profile |
|
|
Homocysteine, Plasma |
|
|
Plasminogen Activator Inhibitor 1 (PAI-1) Activity |
|
|
Sedimentation Rate, Modified Westergren |
|
|
Acute Ischemic Markers |
|
|
Creatine Kinase (CK), MB |
|
|
Creatine Kinase (CK), Total, Serum |
|
|
Myoglobin, Serum |
|
|
Troponin T |
|
|
Novel Markers |
|
|
Tumor Necrosis Factor-α |
|
|
Drug Monitoring |
|
|
Amiodarone (Cordarone®), Serum |
|
|
Digoxin, Serum |
|
|
Prothrombin Time (PT) |
|
|
Heart Failure |
|
|
Galectin-3 |
|
|
Galectin-3 With B-type Natriuretic Peptide |
|
|
Galectin-3 With NT-proBNP |
|
|
NT-proBNP |
|
|
Diabetic Risk |
|
|
Adiponectin |
|
|
Antipancreatic Islet Cells |
|
|
Glucose, Plasma |
|
|
Glutamic Acid Decarboxylase (GAD) Autoantibody |
|
|
Hemoglobin (Hb) A1c |
|
|
Hemoglobin (Hb) A1c With eAG |
|
|
IA2 Autoantibodies |
|
|
Chronic Kidney Disease Assessment |
|
|
Glomerular Filtration Rate, Estimated (eGFR) |
|
|
Other Tests |
|
|
Blood Pressure Unit, One-time Use and Analysis |
|
|
Holter Recorder and Disposable Supplies, One-time Use and Analysis |
|
|
Metabolic Syndrome Profile |
|
|
Patient-activated Event Monitoring (PAEM), Global |
|
|
Tissue Plasminogen Activator (tPA) Activity |
|
|
Transtelephonic 12-lead electrocardiogram (ECG) (For ordering information Call Ambulatory Monitoring Services at 800-289-4345.) |
|
|
Vitamin D, 25-Hydroxy |
|
|
Test Number |
Test Name |
|---|---|
|
*Test includes all coding nucleotides of the specified gene(s), plus at least two and typically 20 nucleotides flanking each coding region. |
|
|
†This is a two-tiered reflexive test. Each tier includes all coding nucleotides of the specified genes, plus at least two and typically 20 nucleotides flanking each coding region. |
|
|
‡Test includes the 200-nucleotide region with exon 26 of APOB where all known FH-associated mutations are located. |
|
|
§For LDLR, test includes all coding nucleotides, plus at least two and typically 20 nucleotides flanking each coding region. For APOB, test includes the 200-nucleotide region with exon 26 of APOB where all known FH-associated mutations are located. |
|
|
Atrial Septal Defect with Atrioventricular Block |
|
|
*Atrial Septal Defect (ASD) With Atrioventricular Block (AVB): NKX2.5 (Full Gene Sequencing) |
|
|
Can confirm clinical diagnosis of HCM and identify at-risk family members before symptoms appear. |
|
|
Early-onset Coronary Heart Disease |
|
|
‡Early-onset Coronary Heart Disease: APOB (Full Gene Sequencing) |
|
|
*Early-onset Coronary Heart Disease: LDLR (Full Gene Sequencing) |
|
|
*Marfan Syndrome (MFS): FBN1 (Full Gene Sequencing) |
|
|
*Pulmonic Stenosis: PTPN11 (Full Gene Sequencing) |
|
|
Genetic Markers |
|
|
Clopidogrel CYP2C19 Genotyping |
|
|
Warfarin (CYP450 2C9, VKORC1) |
|
|
Methylenetetrahydrofolate Reductase (MTHFR) Thermolabile Variant, DNA Analysis |
|
Frozen Gel Packs. To ensure specimen integrity during warm weather, follow these Instructions for Use of frozen gel packs and specimen lockboxes.